top of page
Early DeRisking
What are some of the major issues small molecule drugs face for approval?
+ Some of the major risks for small molecule drug development are driven by one thing - the metabolism of the drug.
+ Understand the metabolism of your molecule early - and you can considerably de-risk from failure or development issues before major investment decisions are made.
+ Running certain in vitro assays early to identify hidden red flags can help de-risk away from these metabolism-mediated liabilities and can significantly add value to your molecule:
Click HERE to learn more about early de-risking strategies in my white paper downloadable from my Resource page
bottom of page